• 목록
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There aren't many studies on how exposure to ADHD for a long time could affect the pregnant fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are required.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should consider the benefits of taking it against the possible risks for the fetus. Physicians don't have the information needed to make unequivocal recommendations, but they can provide information on risks and benefits that help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication in early pregnancy were not at a higher risk of fetal malformations or structural birth defects. Researchers used a large population-based study of case control to examine the prevalence of major structural defects in infants born to mothers who took stimulants during pregnancy. Pediatric cardiologists and clinical geneticists looked over the cases to ensure accurate classification of the cases and to reduce the chance of bias.

The study conducted by the researchers had some limitations. In particular, they were unable to distinguish the effects of the medication from those of the disorder that is underlying. This makes it difficult for researchers to determine whether the small associations observed among the groups that were exposed to the use of medications or affected by the presence of comorbidities. Researchers also did not look at the long-term effects for the offspring.

The study showed that infants whose mothers took ADHD medication during pregnancy had a slightly higher risk of admission to the neonatal care unit (NICU) as compared to those whose mothers did not use any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication that was used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an increased chance of having a caesarean delivery or having a baby born with a low Apgar score (less than 7). These increases appear to be independent of the type of medication taken during pregnancy.

Researchers suggest that the minor risk of using ADHD medication during pregnancies in the early stages can be offset by greater benefits for baby and mother of continued treatment for the woman’s disorder. Physicians should discuss the issue with their patients and, if they are able, assist them in developing strategies for improving their coping skills that can lessen the negative impact of her condition on her daily functioning and relationships.

Medication Interactions

As more women than ever are diagnosed with ADHD and being treated with medication, the dilemma of whether to keep or discontinue treatment during pregnancy is one that more and more physicians have to face. Most of the time, these decisions are made in the absence of any evidence that is clear and definitive regardless, so doctors must weigh what they know, the experiences of other doctors, and what the research suggests about the subject and their best judgment for each patient.

Particularly, the subject of potential risks for the baby can be tricky. The research on this subject is based on observations instead of controlled studies and the results are in conflict. Most studies restrict their analysis to live births, which adhd medication is the best can underestimate the severity of teratogenic effects leading to abortions or terminations of pregnancy. The study presented in this journal club addresses these issues by looking at data from both live and deceased births.

Conclusion: While some studies have found a positive correlation between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. Most studies show a neutral, or even slight negative effect. In the end an accurate risk-benefit analysis must be done in each instance.

It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In fact, in an article published in the Archives of Women's Mental Health, psychologist Jennifer Russell notes that stopping adhd and anxiety medication medication during pregnancy can cause depression, feelings of loneliness and family conflict for these patients. A loss of medication may affect the ability to drive safely and complete work-related tasks, which are essential aspects of everyday life for people with ADHD.

She suggests that women who are unsure whether to continue taking the medication or stop due to pregnancy should educate family members, coworkers, and friends about the condition, its effects on daily functioning, and the benefits of keeping the current treatment plan. It can also make the woman feel more comfortable as she struggles with her decision. Some medications can pass through the placenta. If a patient decides to stop taking her ADHD medication while pregnant and breastfeeding, it's important to be aware that the drug may be transferred to her infant.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns over the impact that these drugs could have on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Using two massive data sets researchers were able look at more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Researchers found that while the overall risk is low, the first trimester ADHD exposure to medication was associated with slightly higher rates of certain heart defects, like ventriculoseptal defects.

The researchers of the study did not discover any link between early use of medication and congenital anomalies such as facial deformities or club feet. The results are in the same vein as previous studies which showed an insignificant, but small increase in the number of cardiac malformations among women who began taking ADHD medication prior to pregnancy. This risk increased during the latter half of pregnancy when many women stopped taking their medication.

Women who took ADHD medication in the first trimester were more likely to need a caesarean and also have a low Apgar after delivery, and had a baby that required help breathing when they were born. The researchers of the study were not able to eliminate selection bias because they limited the study to women who did not have any other medical conditions that might have contributed to the findings.

Researchers hope their research will provide doctors with information when they encounter pregnant women. They suggest that although discussing the risks and benefits is crucial but the decision to stop or maintain treatment must be based on each woman's needs and the severity of her ADHD symptoms.

The authors also caution that even though stopping the medication is an option, it isn't a recommended practice because of the high prevalence of depression and other mental health issues among women who are pregnant or recently post-partum. Further, research shows that women who stop taking their medications will have a tough transitioning to life without them once the baby is born.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women who suffer from ADHD who have to deal with their symptoms while attending doctor appointments as well as getting ready for the arrival of their child and adjusting to new household routines are often faced with a number of difficulties. Many women choose to continue taking their Mild adhd medication (Consultantpsychiatrist99544.life-Wiki.com) medication during pregnancy.

The majority of stimulant drugs pass through breast milk in very small quantities, so the risk to the infant who is breastfeeding is low. The rate of medication exposure will vary based on the dosage the medication is administered, its frequency and time of day. Additionally, different medications are introduced into the baby's system through the gastrointestinal tract or breast milk. The impact on the health of a newborn is not completely known.

Some doctors may decide to stop stimulant medication for adhd and bipolar during a woman’s pregnancy due to the absence of research. This is a difficult decision for the patient, who must balance the benefit of continuing her medication against the potential risks to the fetus. Until more information is available, GPs should ask all pregnant patients about their experience with ADHD and if they are taking or planning to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue taking their ADHD medication safely while breastfeeding and during pregnancy. In response, a growing number of patients are opting to continue their medication. They have found, in consultation with their physicians, that the benefits of keeping their current medication outweigh any risk.

It is crucial for women suffering from ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss their medication with their doctor as well as the pros and cons for continuing treatment. This includes non medication treatment for adhd adults-pharmacological methods. Psychoeducation is also required to help women with ADHD understand their symptoms and the underlying disorder and learn about treatment options and reinforce existing coping strategies. This should include an approach that is multidisciplinary, including the GP doctors, obstetricians and psychiatrists. Counselling for pregnancy should include the discussion of a treatment plan for both the mother as well as the child, monitoring for signs of deterioration and the need for adjustments to the medication regimen.